The first federal Zoloft lawsuit trial slated for MDL 2342 has been postponed until January 2015. The In Re: Zoloft (Sertraline Hydrochloride) Products Liability Litigation is being overseen by the Honorable Cynthia M. Rufe, who issued a pretrial order on May 1 which indicated the case would be pushed back... Read more »

The FDA has released an updated statement on the Pradaxa stomach bleed risk, suggesting that patients taking the drug may have an increased risk of stomach bleeds, compared with warfarin. Pradaxa is a blood-thinning medication used to decrease the risk of stroke and blood clots in patients with non-valvular atrial... Read more »

Celiac disease has been mysteriously on the rise in recent years but a new study has linked some celiac-like symptoms with the use of olmesartan, a popular blood pressure medication commonly sold under the name Benicar. Benicar is a hypertension medication also known under the generic name olmesartan. It is an angiotensin II receptor... Read more »

As the number of testosterone therapy lawsuits continues to rise nationwide, efforts to coordinate the litigation have met with a minor snag. While most companies listed as defendants on these cases agree coordination of litigation is the best choice, one manufacturer of testosterone treatment, is opposing the move. How this... Read more »

More than 100 plaintiffs have filed a Yaz birth control lawsuit in St. Clair County, Illinois claiming they were injured as a result of ingesting Yaz/Yasmin. Iris Colon is one of six Illinois plaintiffs in the lawsuit filed against Bayer Corp., Bayer Healthcare LLC, and Bayer Healthcare Pharmaceuticals Inc. on... Read more »

The Actos trial proceeding in a Las Vegas courtroom recently resulted in some negative publicity for the defendants, Takeda Pharmaceuticals. The lawyers for the defendants were reprimanded by U.S. District Judge Kerry Earley for their unprofessional behavior and they now face sanctions imposed by the Judge. Since the trial began... Read more »

With Pradaxa lawsuits on the rise, drug manufacturer Boehringer Ingelheim just suffered another public relations blow with a new report from the healthcare information company AdverseEvents. The company compared adverse events linked to three new anticoagulant drugs on the market today; finding Pradaxa and Xarelto fell far behind Eliquis in... Read more »